Amine Bahi, a neuroscience researcher in the United Arab Emirates, has had a third paper retracted.
Here’s the notice for “Blockade of Protein Phosphatase 2B Activity in the Amygdala Increases Anxiety- and Depression-Like Behaviors in Mice,” which was posted on November 19: Continue reading Rats! Neuroscientist notches third retraction, this one for using the wrong RNAs
It’s been another busy week at Retraction Watch. Here’s a sampling of scientific publishing and misconduct news from around the web: Continue reading Weekend reads: Stapel as an object lesson, peer review’s flaws, and salami slicing
It’s really hard to get papers retracted, police might be best-equipped to handle scientific misconduct investigations, and there’s finally software that will identify likely image manipulation.
Those are three highlights from a number of pieces that have appeared in Nature and Nature Medicine in the past few weeks. Not surprisingly, there are common threads, so join us as we follow the bouncing ball. Continue reading Should scientific misconduct be handled by the police? It’s fraud week at Nature and Nature Medicine
A group of anesthesiology researchers in China has lost their 2011 paper in Der Anaesthesist because, well, the article wasn’t theirs to begin with.
The paper, “Different anesthesia methods for laparoscopic cholecystectomy,” came from authors at the 309th Hospital of PLA, in Beijing, who purported to report on a randomized trial of 68 patients undergoing laparoscopic colon surgery with either general or spinal (that is, a nerve block) anesthesia. According to the abstract:
Continue reading Same “difference,” as anesthesia paper retracted for plagiarism
Retraction Watch readers will no doubt be familiar with the fact that retraction rates are rising, but one of the unanswered questions has been whether that increase is due to more misconduct, greater awareness, or some combination of the two.
In a new paper in PLOS Medicine, Daniele Fanelli, who has studied misconduct and related issues, tries to sift through the evidence. Noting that the number of corrections has stayed constant since 1980, Fanelli writes that: Continue reading “Why Growing Retractions Are (Mostly) a Good Sign”: New study makes the case
Drug Design, Development and Therapy has retracted a 2013 paper by a group from Italy for duplication.
The retraction notice for the paper, “Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome,” fairly bristles with indignation: Continue reading Cancer-anorexia paper retracted for “unacceptable” duplication
Two researchers who have appeared frequently on Retraction Watch have racked up another retraction each.
This is the fourteenth retraction for Alirio Melendez, who was found guilty of misconduct by the National University of Singapore but denies the allegations. Here’s the notice in The International Journal of Biochemistry & Cell Biology for “Environmental toxicogenomics: A post-genomic approach to analysing biological responses to environmental toxins,” a paper published in Environmental Research and cited nine times, according to Thomson Scientific’s Web of Knowledge: Continue reading Melendez notches retraction 14, Lemus now stands at 12
On November 11, St. Louis’s KTVI reported that krokodil, a nasty opioid concoction with roots in Russia, had arrived in their town. They based that report on a case study published in the American Journal of Medicine, “Krokodil’—A Designer Drug From Across the Atlantic, with Serious Consequences,” and interviewed two of the paper’s authors, Dany Thekkemuriyil and Unnikrishnan Pillai.
The case study involved a 30-year-old man the Thekkemuriyil and Pillai said they had seen at St. Mary’s Health Center in Richmond Heights, Missouri. As the St. Louis Post-Dispatch reported a few days later: Continue reading Drug withdrawal: St. Louis Krokodil paper disappears
A group of mathematicians in Iran have had a second paper retracted, and if we may, neither of the notices adds up.
Here’s the notice: for the new paper, in the Journal of Inequalities and Applications: Continue reading Mathematicians have second paper retracted
It’s been a busy week here at Retraction Watch, with breaking news about hotly debated papers from Nature and about GMOs, but there have been interesting stories about retractions and scientific misconduct elsewhere, too. Here’s a sampling:
Continue reading Weekend reads: China’s scientific publishing black market, how to blow the whistle, and more